1. Home
  2. ROCK vs COLL Comparison

ROCK vs COLL Comparison

Compare ROCK & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gibraltar Industries Inc.

ROCK

Gibraltar Industries Inc.

HOLD

Current Price

$39.76

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$36.80

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROCK
COLL
Founded
1972
2002
Country
United States
United States
Employees
2221
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
ROCK
COLL
Price
$39.76
$36.80
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$50.83
AVG Volume (30 Days)
288.2K
430.2K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.73
Revenue
$1,135,501,000.00
$780,567,000.00
Revenue This Year
$24.00
$5.93
Revenue Next Year
$34.38
N/A
P/E Ratio
N/A
$20.12
Revenue Growth
N/A
23.62
52 Week Low
$37.80
$23.23
52 Week High
$75.08
$50.79

Technical Indicators

Market Signals
Indicator
ROCK
COLL
Relative Strength Index (RSI) 30.35 34.67
Support Level $37.80 $34.29
Resistance Level $51.86 $39.85
Average True Range (ATR) 1.66 1.31
MACD -0.10 -0.12
Stochastic Oscillator 27.56 27.86

Price Performance

Historical Comparison
ROCK
COLL

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: